Therapy of antibody-mediated factor VIII deficiency by immunosuppressive therapy containing cyclophosphamide, dexamethasone and rituximab: A case report

被引：0
|
作者：
Thoedtmann, R. [1 ]
Rosenlechner, S. [1 ]
Unger, J. [1 ]
Patsch, W. [1 ]
Greil, R. [1 ]
机构：
[1] Univ Hosp Salzburg, Salzburg, Austria
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1545
引用
收藏
页码：546 / 546
页数：1
相关论文
共 50 条
  • [1] Acquired Factor VIII deficiency: Rapid and complete remission after immunosuppressive therapy with high dose cyclophosphamide and Rituximab.
    Tamponi, G
    Schinco, P
    Borchiellini, A
    Valpreda, A
    Pollio, B
    Boccadoro, M
    BLOOD, 2002, 100 (11) : 101B - 101B
  • [2] Immunosuppressive Therapy of Antibody-Mediated aHUS and TTP
    Kelen, Kata
    Horvath, Orsolya
    Kis, Eva
    Mikes, Balint
    Sallay, Peter
    Prohaszka, Zoltan
    Szabo, Attila Jozsef
    Reusz, Gyoergy S.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (18)
  • [3] ANTIBODY-MEDIATED REJECTION OF KIDNEY GRAFTS: COMPARISON OF STANDARD THERAPY AND THERAPY WITH ADDITION OF BORTEZOMIB AND/OR RITUXIMAB
    Oblak, Teja
    Lindic, Jelka
    Gubensek, Jakob
    Kveder, Radoslav
    Rigler, Andreja Ales
    Skoberne, Andrej
    Haler, Zeljka Veceric
    Borstnar, Spela
    Avgustin, Nusa
    Ponikvar, Rafael
    Mlinsek, Gregor
    Ferluga, Dusan
    Kojc, Nika
    Godnov, Uros
    Kovac, Damjan
    TRANSPLANT INTERNATIONAL, 2017, 30 : 554 - 554
  • [4] ANTIBODY-MEDIATED REJECTION OF KIDNEY GRAFTS: COMPARISON OF STANDARD THERAPY AND THERAPY WITH ADDITION OF BORTEZOMIB AND/ OR RITUXIMAB
    Oblak, Teja
    Lindic, Jelka
    Kveder, Radoslav
    Rigler, Andreja Ales
    Skoberne, Andrej
    Haler, Zeljka Veceric
    Borstnar, Spela
    Avgustin, Nusa
    Gubensek, Jakob
    Ponikvar, Rafael
    Mlinsek, Gregor
    Ferluga, Dusan
    Kojc, Nika
    Kovac, Damjan
    TRANSPLANT INTERNATIONAL, 2017, 30 : 386 - 386
  • [5] Immunosuppressive therapy for acquired hemophilia with cyclophosphamide, vincristine and prednisone after factor VIII stimulation
    Durig, J
    deWit, M
    Fiedler, W
    Marx, G
    Hossfeld, DK
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1996, 126 (47) : 2026 - 2031
  • [6] Cyclophosphamide salvage therapy for IVIG/PLEX-resistant antibody-mediated rejection
    Caumartin, Yves
    Habhab, Wael
    Ball, Edward
    Leckie, Steve
    Luke, Patrick P.
    Jevnikar, Anthony
    JOURNAL OF UROLOGY, 2008, 179 (04): : 664 - 665
  • [7] Cyclophosphamide a novel therapy for IVIG/PLEX-resistant antibody-mediated rejection
    Habhab, Wael
    Caumartin, Yevs
    House, Andrew
    Muirhead, Norman
    Rehman, Faisal
    Luke, Patrick
    McAlister, Vivian
    Moussa, Madelaine
    Ball, Edward
    Jevnikar, Anthony M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 239 - 239
  • [8] Dexamethasone cyclophosphamide pulse therapy in lichen amyloidosus: A case report
    Gupta, Ramji
    Gupta, Sarthak
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2007, 18 (04) : 249 - 251
  • [9] Rituximab-associated PRES in antibody-mediated kidney rejection: A case report
    Etemadifar, Masoud
    Alaei, Seyyed-Ali
    Saffari, Elahe
    Salari, Mehri
    TRANSPLANT IMMUNOLOGY, 2023, 80
  • [10] Successful rescue and maintenance of long-term remission of anti-HLA antibody-mediated acute allograft rejection by rituximab-containing therapy: case report
    Takeuchi, Yasuo
    Yoshida, Kazunari
    Wakai, Haruki
    Obata, Fumiya
    Aita, Kumi
    Koike, Junki
    CLINICAL TRANSPLANTATION, 2008, 22 : 50 - 52
12345